Michel Charbonneau, executive VP at Accord Healthcare Inc. touches upon the rapid evolution of the Canadian affiliate over the past five years, and the company’s commitment to bringing high-quality, innovative, affordable generics to patients. He furthermore expresses his hopes for collaboration between generic players in the Canadian pharmaceutical industry in light of recent supply issues in Canada.
Michel, you have been Executive Vice-President of Accord for five years now. What goals were set for your tenure?
"Our evolution in Canada has been quite successful and I think we have been able to demonstrate that we are committed and here to stay."
